UnitedHealth Group Incorporated (UNH)
Healthcare · Medical - Healthcare Plans · Data as of 2026-10-22
Bottom line
UNH is trading near its usual valuation, in the middle of its recent price range, and recent volume shows no clear direction. The picture is mixed, so it may be worth watching rather than acting on. Past patterns are not a guarantee of future results.
Valuation — Trading near its usual range (Yellow)
UNH trades at 24× earnings, roughly in line with its own 5-year average of 25× and roughly in line with similar healthcare companies we track (28×, 53 peers). That is roughly what the market has typically paid for this stock. Its free-cash-flow yield is about 6.0%. Growth is slower than its 3-year pace, which deserves some caution. Its current multiple sits around the 51st percentile of its own last five years — around the middle of its own range.
Price zones — In the middle of its recent range (Yellow)
At $424.98, the stock sits between its recent support and resistance levels. Over the past year UNH has traded between $255.97 and $461.62; its historical support zone sits near $388.19 and resistance near $461.62. It is above both its 50- and 200-day averages, which has historically signalled an uptrend.
52-week range $255.97–$461.62 · 50-day average $388.19 · 200-day average $360.65
Money flow — No clear direction (Yellow)
Buying and selling volume in UNH have been fairly balanced recently, with no strong accumulation or distribution pattern. Volume on up days has been about 0.9× volume on down days over the last 30 sessions.
Dividends & company facts
UNH paid $9.06 a share in dividends over the past year — 2.1% of today's price — and has raised it in each of the last five years. It also bought back shares: $5.5 billion in fiscal 2025, about 1.4% of its market value.
- Dividend yield (12 months)
- 2.13%
- Paid over 12 months
- $9.06 a share
- Payout ratio
- 51.4%
- Buybacks
- 1.45% (fiscal 2025)
- Shares, past year
- -1.1%
- Revenue, 12 months
- $449.7B
- Profit, 12 months
- $15.9B
- Employees
- 390,000
- CEO
- Stephen J. Hemsley
- Headquarters
- Eden Prairie, MN
- Listed since
- 1984 · NYSE
About the company
UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment provides a wide array of health benefit plans and consumer-focused services. These offerings cater to a broad spectrum of clients, including large national corporations, public sector employers, mid-sized and small businesses, and individual consumers.
Related stocks
一句话结论
UNH 估值接近其惯常水平，处于近期价格区间的中部，近期成交量没有明确方向。整体情况好坏参半，也许更适合先观察，而不是急于行动。过去的形态并不能保证未来的结果。
估值 — 处于其惯常的估值区间
UNH 目前的市盈率为 24×，大致持平于其自身 5 年平均的 25×，并且大致持平于我们追踪的同类Healthcare公司（28×，53 家）。这大致就是市场以往为这只股票所付出的水平。其自由现金流收益率约为 6.0%。增速已慢于其 3 年的平均步伐，这一点值得留意。它当前的估值倍数大约位于自身过去五年分布的第 51 百分位——处于自身区间的中部。
价格区间 — 处于近期区间的中部
目前价格为 $424.98，位于其近期的支撑位与阻力位之间。过去一年 UNH 的价格在 $255.97 到 $461.62 之间波动；其历史支撑区在 $388.19 附近，阻力区在 $461.62 附近。它同时位于 50 日和 200 日均线上方，这在历史上通常对应上升趋势。
资金流向 — 方向不明确
UNH 近期的买卖成交量大致均衡，没有明显的吸筹或派发形态。过去 30 个交易日，上涨日的成交量约为下跌日的 0.9×。
股息与公司概况
UNH 过去一年每股派息 9.06 美元，相当于当前股价的 2.1%，过去五年每年都有上调。它也回购了股票：2025 财年回购 55.5亿美元，约占市值的 1.4%。
UnderTheLight 用直白的语言解释股票——估值、价格区间与资金流向。它只描述数据，不构成任何投资建议。
UnderTheLight explains stocks in plain English — valuation, price zones and money flow as traffic lights, recomputed nightly. It describes data; it is not investment advice and never recommends a trade.